期刊文献+

siRNA沉默细胞外信号调节激酶1/2基因协同甲亢宁胶囊对大鼠甲状腺细胞-5细胞增殖的影响 被引量:5

Effects of si RNA Silenced ERK1/2 Gene Collaborated with Jiakangning Capsules on FRTL-5 Proliferation
下载PDF
导出
摘要 目的通过甲亢宁胶囊(以下简称"甲亢宁")协同si RNA干扰大鼠甲状腺细胞-5(fisher rat thyroid cell line-5,FRTL-5)中细胞外信号调节激酶(ERK)1/2基因,观察并探讨甲亢宁对FRTL-5细胞RNA干扰ERK1/2基因表达及对FRTL-5细胞增殖的影响。方法将生长状态良好的FRTL-5细胞分为空白组、阴性对照组、甲亢宁组、si RNA组、甲亢宁协同组。利用si RNA沉默及甲亢宁协同干扰FRTL-5细胞的ERK1/2基因,RT-PCR检测ERK1/2 m RNA表达,Western blot检测ERK1/2、p-ERK1/2蛋白表达,CCK8法检测细胞增殖。结果 RT-PCR检测结果显示,空白组和阴性对照组ERK1/2的m RNA表达无明显差异(P>0.05);与空白组比较,si RNA组和甲亢宁组FRTL-5细胞ERK1/2 m RNA表达明显下降(P<0.01);与空白组、阴性对照组比较,甲亢宁协同组ERK1/2 m RNA表达明显下降(P<0.01);Western blott检测结果显示,与空白组、阴性对照组比较,甲亢宁组、si RNA组、甲亢宁协同组p-ERK1/2、ERK1/2蛋白表达相对量明显下降(P<0.01)。转染24、48 h后,CCK8法检测结果显示,甲亢宁组、si RNA组、甲亢宁协同组细胞增殖受抑制,与空白组、阴性对照组比较差异有统计学意义(P<0.01)。结论甲亢宁对ERK1/2磷酸化起阻断作用,ERK1/2基因被沉默后,对甲状腺细胞增殖有抑制作用,甲亢宁可协同ERK1/2-si RNA抑制FRTL-5细胞增殖。 Objective To observe and explore the effects of Jiakangning Capsules on the expression of ERK1/2gene and proliferation of FRTL-5 by studying the effects of Jiakangning Capsules collaborated with siRNA oninterfering ERK1/2 gene in FRTL-5. Methods FRTL-5 cells in good conditions were divided into control group,negative control group, Jiakangning Capsules collaborated with siRNA group, siRNA interference group, andJiakangning Capsules group. RT-PCR was performed to detect the expression of ERK1/2 gene in mRNA levels inFRTL-5; Western blotting was performed to detect the expressions of ERK1/2 and p-ERK1/2; CCK8 method was usedto detect cell proliferation. Results RT-PCR results showed that the ERK1/2 mRNA expression of the control groupand negative control group were of no significant difference (P〉0.05); compared with the control group, siRNAinterference group and Jiakangning Capsules group could inhibit ERK1/2 gene mRNA expression in FRTL-5(P〈0.01). Compared with the control group and negative control group, the ERK1/2 mRNA expression ofJiakangning Capsules collaborated with siRNA group decreased obviously (P〈0.01). Compared with the controlgroup and negative control group, the expression of p-ERK1/2, ERK1/2 of Jiakangning Capsules group, Jiakangning Capsules collaborated with siRNA group, and siRNA interference group decreased obviously (P〈0.01). At the time of24 h and 48 h after transfection, according to the results of CCK8, compared with the control group and negativecontrol group, the cell proliferation of Jiakangning Capsules group, Jiakangning Capsules collaborated with siRNAgroup, and siRNA interference group was inhibited (P〈0.01). Conclusion Jiakangning Capsules have blocking effecton the phosphorylation of ERK1/2. After ERK1/2 gene was silenced, the thyroid cell proliferation was inhibited.Jiakangning Capsules can collaborate with ERK1/2-siRNA to inhibit FRTL-5 cell proliferation.
出处 《中国中医药信息杂志》 CAS CSCD 2016年第6期43-46,共4页 Chinese Journal of Information on Traditional Chinese Medicine
基金 国家自然科学基金(81173260)
关键词 甲状腺细胞 细胞外信号调节激酶1/2 甲亢宁胶囊 RNA干扰 增殖 thyroid cell ERK1/2 Jiakangning Capsules RNA interference proliferation
  • 相关文献

参考文献7

  • 1中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:835
  • 2司富春,宋雪杰.中医治疗甲亢的证候和方药分析研究[J].中华中医药杂志,2013,28(11):3250-3255. 被引量:25
  • 3秦淑兰,邱柳芸,刘小华,等.131I与抗甲状腺药物治疗甲状腺功能亢进症的Meta分析[J].中华临床医师杂志(电子版),2013,7(19):8799-8803.
  • 4GLENNON P E, KADDOURS S, SALE E M, et al. Depletion ofmitogen-activated protein kinase using an antisenseoligodeoxynucleo-tide approach downregulates the phenylephrineinducedhypertrophic response in rat cardiac myocytes[J]. CircRes,1996,78(6):954-961.
  • 5CAMBELL P M. Oncogenic Ras Pushes (and Pulls) cell cycleprogression through ERK activation[J]. Methods Mol Biol,2014,1170:155-163.
  • 6WASEEM T, DUXBURY M, ASHLEY S W, et al. Ghrelin promotesintestinal epithelial cell proliferation through PI3K/Aktpathway and EGFR transactivation both converging to ERK1/2phosphorylation[J]. Peptides,2014,52:113-121.
  • 7林兰,李鸣镝,刘喜明,王兆礼,楚晓燕,张润云.中药甲亢宁治疗阴虚阳亢型甲状腺功能亢进症的临床研究[J].中国中西医结合杂志,1999,19(3):144-147. 被引量:31

二级参考文献26

  • 1赵家胜.甲亢性心脏病发病机理研究进展[J].国外医学(内分泌学分册),1997,17(1):13-15. 被引量:82
  • 2中华人民共和国卫生部颁布制订.中药新药临床研究指导原则,第二辑[M].,1995.163.
  • 3石福彦.甲状腺功能异常时的心钠素改变[J].国外医学:内分泌学分册,1990,(1):35-35.
  • 4陆再英,钟南山内科学.北京:人民卫生出版社.2008.
  • 5赵家胜,国外医学.内分泌学分册,1997年,1期,13页
  • 6中华人民共和国卫生部,中药新药临床研究指导原则.2,1995年,163页
  • 7石福彦,国外医学.内分泌学分册,1990年,1期,35页
  • 8张伯臾,中医内科学,1985年,484页
  • 9白耀.甲状腺病学-基础与临床[M].北京:科学技术文献出版社,2004.388.
  • 10Davies TF, Larsen PR. Thyrotixicosis// Larsen PR, Kronenberg HM, Melmed S. Wlilliams textbook of endocrinology. 10th ed. Philadelphia: Saunders, 2002: 374-424.

共引文献886

同被引文献102

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部